BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Mergers and Acquisitions
Shire Goes Shopping After AbbVie (ABBV) Deal Falls Through 10/20/2014
Virax To Acquire Deep AKT Inhibitor Portfolio Already In Phase 1b/2 Breast & Phase 1b Ovarian Cancer Trials 10/17/2014
Horizon Biopharm Pays $45 Million Cash For U.S. Rights To PENNSAID® 2% 10/17/2014
DiaGenic ASA: Completed Acquisition Of NEL Hydrogen – Company Name And Ticker To Be Changed 10/17/2014
Lawyers Have Documents That Prove Allergan Inc. (AGN) Misled Investors About Valeant (VRX): Ackman 10/17/2014
AbbVie (ABBV) Board Officially Abandons $55 Billion Shire Merger 10/16/2014
Shire Plummets As AbbVie (ABBV) Reconsiders $55 Billion Takeover Bid 10/16/2014
MorphoSys AG Acquires Lanthipeptide Technology From Lanthio Pharma 10/15/2014
Princeton University Acquires Protea Biosciences, Inc.'s LAESI® Technology Platform 10/15/2014
Spotlight Innovation Signs Letter Of Intent To Acquire Memcine Pharmaceuticals 10/15/2014
Analysts Still See AstraZeneca PLC (AZN) As Viable Takeover Target 10/15/2014
Geographic Split Likely For GlaxoSmithKline (GSK) Mature Drugs Sale 10/15/2014
Becton, Dickinson and Company (BDX) Acquires GenCell Biosystems 10/13/2014
Oxford BioMedica PLC (OXB.L) Acquires Windrush Court Office And Laboratory Facilities 10/13/2014
Fosun International Ltd. Pays $607 Million For Portuguese Hospital Chain 10/13/2014
Fidelity Ups Its Stake In Allergan Inc. (AGN) As Actavis (ACT) Bid Rumors Fly; Potential $60 Billion Deal 10/10/2014
Bay Area's IMPAX Laboratories, Inc. (IPXL) Snags Two Private Drugmakers For $700 Million Cash 10/10/2014
QLT Inc. (QLTI) Announces Merger With Auxilium Pharmaceuticals (AUXL) Terminates For Superior Proposal 10/9/2014
GlaxoSmithKline (GSK) Takes A 25% Stake In Aspen Pharmacare Ltd. Japanese Unit 10/9/2014
Roche (RHHBY) Acquires Rights To Technology And Patent Applications From Abvitro To Support Next-Generation Sequencing Pipeline 10/9/2014
Endo International plc (ENDP) Pays $2.6 Billion For Auxilium Pharmaceuticals (AUXL), Auxilium Drops QLT Inc. (QLTI) Deal 10/9/2014
Valeant (VRX) Will Sweeten Allergan Inc. (AGN) Bid To Clinch Deal 10/9/2014
Actavis (ACT) Plots New Merger Approach For Allergan Inc. (AGN) 10/8/2014
DiaGenic ASA Signed Final Agreement To Acquire NEL Hydrogen AS – Extended Announcement 10/8/2014
Teva Pharmaceutical Industries Limited (TEVA) To Stop R&D In Cancer And Women's Health; 14 Pipeline Projects To End, Divest 10/7/2014
Top Managers Argue Over What To Do With Sanofi (SAN.PA)'s $8 Billion Drug Portfolio 10/7/2014
Analyst Dismisses Teva Pharmaceutical Industries Limited (TEVA)-Mylan Inc. (MYL) Merger Rumor 10/7/2014
Cognizant (CTSH) Acquires Cadient Group To Help Clients Drive Business Transformation Through Digital Technologies 10/7/2014
Actavis (ACT) Finally Makes A Move, Pays $675 Million For Durata Therapeutics, Inc.  (DRTX) 10/6/2014
Week in Review: WuXi PharmaTech Co., Ltd. Acquires XenoBiotic Laboratories, Inc. , A US-China CRO 10/6/2014
Salix Pharmaceuticals, Ltd. (SLXP) Linked With Actavis (ACT) After Calling Off Cosmo Pharmaceuticals S.p.A. Merger Amid Inversion Crackdown 10/3/2014
Arbor Pharmaceuticals Explores $1 Billion+ Sale 10/3/2014
PAREXEL International (PRXL) Announces Acquisition Of Clinintel, Extending Leadership In Randomization And Trial Supply Management 10/3/2014
Soluble Therapeutics Grabs Seattle-Based Biotech Dilyx Biotechnologies 10/3/2014
Sagent Pharmaceuticals, Inc. Bags Omega Laboratories For $85.3 Million Cash 10/2/2014
Novasep To Sell Its Bahamian Plant To Local Investor 10/2/2014
The Dow Chemical Company (DOW) Provides Updates On Planned Divestments Progress And Outlines Additional Portfolio Actions 10/2/2014
Stemgent, Inc. Sells The Stem Cell Reagent And Services Business Unit 10/2/2014
Neogen Corporation (NEOG) Acquires BioLumix 10/2/2014
Prima Biomed (PRR.AX) Secures $37.4 Million To Fund Immutep S.A. Acquisition 10/2/2014
Catalent Pharma Solutions (CTLT) Expands Its Technology Offerings In Biologics, Acquires Redwood Bioscience Inc. And The SMARTag™ Technology Platform 10/2/2014
Immutep S.A. Picks Up Prima Biomed (PRR.AX) For $28 Million 10/2/2014
Johnson & Johnson (JNJ) Bags SSF's Alios BioPharma For $1.7 Billion Cash 10/1/2014
Akorn, Inc. (AKN) Ponies Up $45 Million Cash For Sunovion Pharmaceuticals Inc.'s Xopenex® (levalbuterol HCI) Inhalation Solution 10/1/2014
After Snagging 18 Products From AstraZeneca PLC (AZN), IGI Laboratories, Inc. Grabs Two More From Valeant (VRX) 10/1/2014
Oncore Grabs Enantigen Therapeutics For Undisclosed Amount 10/1/2014
Islet Sciences, BHV Pharma, Inc. Merges; Combined Company To Be Named Avogenx 10/1/2014
WuXi PharmaTech Co., Ltd. Laboratory Testing Division Expands In U.S. With Acquisition Of XenoBiotic Laboratories, Inc. 10/1/2014
Harvard Bioscience Inc. (HBIO) Acquires Multi Channel Systems MCS GmbH And Triangle BioSystems, Inc. 10/1/2014
Consort Medical Scoops Up Aesica For $374 Million 10/1/2014
Recipharm AB Completes Acquisition Of Corvette Pharmaceutical Services Group For SEK1.1 Billion 10/1/2014
Merck & Co. (MRK) Completes Sale Of Consumer Care Business To Bayer AG (BAYZF) For $14.2 Billion 10/1/2014
Chindex International, Inc. (CHDX) Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 9/30/2014
Cellular Biomedicine Group (CBMG) Completes Acquisition Of Agreen Biotech Co Ltd. 9/30/2014
Strides Arcolab Limited Snags Shasun Pharma In All Stock Deal Worth Over $221 Million 9/30/2014
Chiltern International Ltd. Acquires Pacific Clinical Research Pte Limited And Expands Operations And Therapeutic Depth In Asia-Pacific 9/29/2014
Ex-Elan Corporation PLC (ELN) Trio Snags Their Former Employer’s Kinase Inhibitor Program 9/29/2014
Daiichi Sankyo, Inc. (4568.t) Boosts Cancer Pipeline With $410 Million Ambit Biosciences Buy 9/29/2014
Hikma Pharmaceuticals Eyeing $1 Billion Bid For U.S. Rival CorePharma LLC 9/29/2014
Life Sciences M&A Stays White Hot As Buying Spree Continues 9/29/2014
AMAG Pharmaceuticals, Inc. (AMAG) Shells Out $675 Million For Women's Health Company Lumara Health 9/29/2014
Abbott Laboratories (ABT) Completes Acquisition Of CFR Pharmaceuticals; Announces Results Of Tender Offer For CFR Shares 9/26/2014
IGI Laboratories, Inc. Scores Eighteen Former Products From AstraZeneca PLC (AZN) 9/25/2014
Allergan Inc. (AGN) Issues Statement Regarding Recent Valeant Pharmaceuticals International (VRX) Correspondence 9/25/2014
PPD, Inc. (PPDI) Exercises Option To Acquire Remaining Interest In X-Chem 9/25/2014
Cambridge Healthtech Institute Announces The Acquisition Of OpenHelix 9/25/2014
Scleroderma Foundation Of Southern California And Greater San Diego Chapter Merge To Enhance Support And Education For Scleroderma Patients 9/25/2014
Pfizer (PFE) Approached Actavis (ACT) For Possible Merger 9/24/2014
Acorda Therapeutics (ACOR) Snaps Up Civitas Therapeutics In $525M Cash Deal 9/24/2014
Allergan Inc. (AGN) Rejected Actavis (ACT), Continues Courting Salix Pharmaceuticals, Ltd. (SLXP) 9/23/2014
Merck KGaA (MKGAF.PK) To Pay $17 Billion For St. Louis-Based Sigma-Aldrich Corporation (SIAL) 9/23/2014
Bionomics Limited (BNO.AX) Acquires Prestwick Chemical 9/23/2014
Horizon Pharma plc.  (HZNP) Completes Acquisition Of Vidara Therapeutics 9/22/2014
Auxilium Pharmaceuticals (AUXL) Rejects $2.2B Bid From Endo International plc (ENDP), While QLT Inc. (QLTI) Merger Looks More Likely 9/22/2014
Allozyne, Inc. Sold For Scrap As MedImmune (AZN) Snaps Up Rights 9/22/2014
NovaDel Pharma (NVD) Announces The Sale Of Its Zolpimist® New Drug Application, License And Intellectual Property To Amherst Pharmaceuticals 9/22/2014
PCI Significantly Expands Global Clinical Services Business Through Biotec Acquisition 9/19/2014
Cambridge Healthtech Institute & Knowledge Foundation Acquire The International Battery Seminar & Exhibition 9/18/2014
Denovo Biopharma Acquires Late-Stage Oncology Drug From Eli Lilly and Company (LLY) For Development As A Personalized Medicine 9/17/2014
QLT Inc. (QLTI) Provides Update On Merger With Auxilium Pharmaceuticals (AUXL) 9/17/2014
Hikma Pharmaceuticals Completes Acquisition Of Ben Venue Laboratories Manufacturing Site 9/17/2014
Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) Buys Rights To Tildrakizumab From Merck & Co. (MRK) For An Upfront Payment Of $80 Million 9/17/2014
Asian Investor In Talks To Buy, Build Massive Burlingame Site; Will It Hold Biotech Or Tech Tenants? 9/17/2014
Auxilium Pharmaceuticals (AUXL) Institutes "Poison Pill" To Fend Off $2.2B Endo Pharmaceuticals (ENDP) Offer 9/17/2014
Salix Pharmaceuticals, Ltd. (SLXP) Faces Shareholder Revolt On Cosmo Pharmaceuticals S.p.A. Deal 9/17/2014
Google Inc. Dives Deeper Into Biotech With Lift Labs Acquisition 9/15/2014
Akashi Therapeutics Acquires Global Rights To Novel DMD Treatment From Tonus Therapeutics 9/15/2014
Sanofi (France) (SAN.PA) Aims For M&A With Genzyme Corporation (GENZ) 9/12/2014
Illinois-Based Akorn, Inc. (AKN) Eyes $2 Billion UCB SA Unit In Potential Tax Inversion Deal 9/12/2014
More Than 35% Of Allergan Inc. (AGN) Investors Demand Special Meeting; Support For Valeant (VRX) Merger Grows 9/12/2014
Mergers Hamper Innovation, Ex-Pfizer (PFE) Top Exec Says 9/11/2014
VWR International, LLC Expands European Tissue Diagnostics Portfolio With Acquisition Of Klinipath BV 9/10/2014
Kolltan Pharmaceuticals Inc. Acquires Xetrios Therapeutics And Exclusive Rights To Salk Institute for Biological Studies Patents Related To The TAM Receptor Tyrosine Kinase Family 9/10/2014
Mylan Inc. (MYL) Scoops Up Injectable Arixtra For $300 Million From Aspen Global Inc. 9/10/2014
Jazz Pharmaceuticals plc (JAZZ) Stock Up On Allergan Inc. (AGN) Rumor 9/9/2014
Aceto Corporation Subsidiary, Rising Pharmaceuticals, Inc, Acquires The Ownership Of Three Soft Gel ANDA's From Par Pharmaceutical, Inc. 9/9/2014
Kinex Pharmaceuticals Completes Acquisition Of QuaDPharma 9/9/2014
ReproCELL Acquires The iPS Cell Business Unit Of Stemgent, Inc. 9/9/2014
Momenta Pharmaceuticals, Inc. (MNTA) Exercises Option To Acquire Novel Antibodies From AnaptysBio, Inc. 9/8/2014
Neos Therapeutics Acquires All Commercialization And Profit Rights To Generic Tussionex® (Extended Release Hydrocodone Polistirex/Chlorpheniramine Polistirex) From Chiesi USA And Coating Place, Inc. 9/8/2014
Envision Pharmaceutical Completes Its Acquisition Of Medtrak Services 9/8/2014
Medican Moves Toward Closing The Purchase Of 51 Percent Of International Herbs Medical Marijuana Ltd. (IHMML) 9/8/2014
Soligenix (SNGX) Expands Pipeline With Acquisition Of Phase 3-Ready Oncology Clinical Program 9/5/2014
WellSpring Pharmaceutical Corporation Acquires BONINE®, An Over-The-Counter Drug For Motion Sickness, From Prestige Brands, Inc. 9/5/2014
DPT Laboratories, Ltd. Acquires Meda Pharmaceuticals’ Lakewood, New Jersey, Location 9/4/2014
Cellectis (ALCLS) Announces The Closing Of The Sale Of Its Swedish Subsidiary Cellectis AB To Takara Bio 9/4/2014
China Biologic Products Completes Transaction To Acquire Additional Equity Stake In Guizhou Taibang 9/4/2014
PPD, Inc. (PPDI) Acquires RCT Logic’s Exclusive License To Patented Clinical Trial Design Technology 9/3/2014
Albemarle Corporation (ALB) Completes Sale Of Antioxidant, Ibuprofen And Propofol Businesses To SI Group 9/3/2014
Eisai Inc. (ESALF.PK) Sells U.S. Rights To Zonegran® (zonisamide) Capsules To Concordia Pharmaceuticals 9/3/2014
MWI Veterinary Supply Acquires Vetspace 9/3/2014
Mercachem Holding B.V. To Acquire Prague Business From Synthon 9/3/2014
AstraZeneca PLC (AZN) Pops On Possibility Of Another Pfizer (PFE) Bid; Start Of New Cancer Trial 9/2/2014
BioLegend Acquires The Antibody Products Business Unit From Covance Inc. (CVD) 9/2/2014
Luye Pharma Buys Majority Stake In Beijing Jialin For $599 Million 8/29/2014
Bayer AG (BAYZF), Boehringer Ingelheim Corporation, Perrigo Company (PRGO), And Sanofi (France) (SAN.PA) Linked To Omega Pharma NV (0OMEP.BR) Sale; Deal Could Cost More Than $5.3 Billion 8/29/2014
Johnson & Johnson (JNJ) Seeks Buyer For Struggling Medical Device Unit Cordis Corporation (JNJ); Deal Could Fetch Up To $2 Billion 8/29/2014
Tau Therapeutics, LLC And Xdynia Merge To Form Cavion 8/28/2014
Seragon Pharmaceuticals Announces Closing Of Its Acquisition By Genentech (RHHBY) 8/28/2014
Achillion Pharmaceuticals, Inc. (ACHN) Hits One Year High After Rumors Gilead Sciences, Inc. (GILD) Might Buy It Out 8/28/2014
Facing Shareholder Demands, Allergan Inc. (AGN) Reluctantly Sets A Date For Special Meeting 8/27/2014
Roper Industries Announces Two Medical Acquisitions 8/27/2014
Synexus Further Expands Its Global Footprint With An Acquisition In South Africa 8/27/2014
DPx Holdings B.V. Reaches Definitive Agreement To Acquire Gallus Biopharmaceuticals, LLC 8/27/2014
Novo Nordisk A/S (NVO) Prefers To Grow On Its Own, Not Buy Others: CEO 8/27/2014
Disappointment Looms As Roche (RHHBY) Drops Plans To Bid For The Rest Of Chugai Pharmaceutical Co., Ltd. (Japan) 8/26/2014
VIVUS, Inc. (VVUS) Snags A Group Of Topiramate Patents From Johnson & Johnson (JNJ) 8/26/2014
Cannabis Science Inc. In Final Negotiations To Acquire British Columbia Company That Has Submitted 'Marihuana For Medical Purposes' License Application To Health Canada 8/26/2014
Roche (RHHBY) Pays $8.3 Billion For Bay Area's InterMune, Inc. (ITMN), Pledges To Keep Employees 8/26/2014
Janssen Pharmaceutical Inc. Affiliate Cilag GmbH International Acquires Covagen AG 8/25/2014
China Biologic Products Pays $87 Million For Additional 20 Percent Stake In Subsidiary 8/25/2014
Omnicell Closes Acquisition Of UK-Based Surgichem Limited And Updates 2014 Guidance 8/25/2014
Pfizer (PFE) Eyes Possible Actavis (ACT) Bid Whilst Weighing Next Steps Over AstraZeneca PLC (AZN) 8/22/2014
Mylan Inc. (MYL) Makes Second Round Of Bidding For GlaxoSmithKline (GSK) Drug Portfolio 8/22/2014
Allergan Inc. (AGN) Loses Battle To Make Shareholder Vote Moot On Valeant Pharmaceuticals International (VRX) Bid 8/22/2014
DrugDev Acquires Award-Winning Trialnetworks Platform, Launches Innovation Lab, Unveils Investigator Databank Website And Reaches $1 Billion In Global Site Payments In First Half Of 2014 8/21/2014
Allergan Inc. (AGN) Approaches Salix Pharmaceuticals, Ltd. (SLXP) To Fend Off Valeant Pharmaceuticals International (VRX)'s Hostile Bid 8/20/2014
Pozen, Inc. (POZN) Announces U.S. Rights For TREXIMET® Have Been Acquired By Pernix Therapeutics, Inc. (PTX) 8/20/2014
Clinigen Group Further Strengthens Oncology Support Portfolio With Acquisition Of Ethyol® (Amifostine), From AstraZeneca PLC (AZN) 8/20/2014
Pharming Group (PHGUF.PK) Acquires New Product Leads Through The Acquisition Of Certain Assets Of TRM SASU For € 0.5 Million In Cash 8/19/2014
Salix Pharmaceuticals, Ltd. (SLXP) Announces Early Termination Of HSR Waiting Period For Pending Transaction 8/19/2014
Sweden's Recipharm AB Pays $160 Million For Corvette Pharmaceutical Services Group 8/19/2014
Cubist Pharmaceuticals, Inc. (CBST) Could Be An Acquisition Target For Needy Pfizer Inc. (PFE) 8/19/2014
Confirmed: Novartis AG (NVS) To Invest In Gamida Cell Ltd., Could Buy Out Company In $635 Million Cancer Deal 8/19/2014
Conflicting Reports Surface Over Roche Holding AG (RHHBF.PK)'s $10 Billion Deal, Chugai Pharmaceutical Co., Ltd. (Japan) Denies Talks 8/19/2014
InterMune, Inc. (ITMN) Goes Up On The Block; GlaxoSmithKline (GSK), Roche (RHHBY), Sanofi (France) (SAN.PA) Line Up 8/18/2014
Deal Is Back On: Novartis AG (NVS) To Invest Heavily In Gamida Cell Ltd. Before Acquisition 8/18/2014
GTCR Completes Acquisition Of Cole-Parmer Instrument Company 8/18/2014
Valeant Pharmaceuticals International (VRX) Extends Offer To Acquire Allergan Inc. (AGN) 8/18/2014
Roche (RHHBY) May Gobble Up The Rest Of Chugai Pharmaceutical Co., Ltd. (Japan) For $10 Billion 8/15/2014
Mallinckrodt Pharmaceuticals (MNK) Completes Acquisition Of Questcor Pharmaceuticals, Inc. (QCOR) 8/15/2014
SEC Investigating Valeant Pharmaceuticals International (VRX), Pershing Square's Hostile Takeover Bid For Allergan Inc. (AGN) 8/15/2014
Merck KGaA (MKGAF.PK) CEO Eyes Interesting Takeover Targets 8/14/2014
Allergan Inc. (AGN) Grabs TARIS Biomedical's Lead Program In Deal Worth $587.5 Million 8/14/2014
Mallinckrodt And Questcor Pharmaceuticals, Inc. (QCOR) Shareholders Approve Mallinckrodt's Acquisition Of Questcor 8/14/2014
Miltenyi Biotec, Inc. Acquires Gene Therapy Assets From Lentigen Corporation 8/14/2014
Valeant Pharmaceuticals International (VRX) Receives FTC Second Request Under Hart-Scott-Rodino 8/13/2014
SkyePharma Inc. (SKYE) Acquires A Novel Inhaled Therapy Platform 8/13/2014
uniQure Acquires Cardiology Gene Therapy Company InoCard 8/12/2014
Akorn, Inc. (AKN) Completes Acquisition Of VersaPharm 8/12/2014
Oncothyreon Inc. (ONTY) Announces Acquisition Of Alpine Biosciences 8/12/2014
Boehringer Ingelheim Vetmedica, Inc. Acquires Licensing Rights For Artilysin® Technology From Lysando AG 8/12/2014
DRI Capital Pays Rush University Medical Center $42 Million For AMPYRA® Royalty Rights 8/12/2014
Allergan Inc. (AGN) Receives Second Request From Federal Trade Commission Regarding Valeant Pharmaceuticals International (VRX)’s Unsolicited Acquisition Proposal 8/11/2014
NextSourceCS Acquires Amatheon Compounding Services In An Effort To Help Alleviate The Absence Of Critical Discontinued Drugs In The Veterinary Industry 8/8/2014
Advisor ISS Backs Ackman's Call For Allergan Inc. (AGN) Meeting, Event Could Support The Removal Of Directors, Sale To Valeant Pharmaceuticals International (VRX) 8/7/2014
Endo International plc (ENDP) Completes Acquisition Of DAVA Pharmaceuticals 8/7/2014
After Layoff News, Novartis AG (NVS)'s New York Campus Officially Goes On The Market 8/7/2014
AstraZeneca PLC (AZN), Shire Slip As The U.S. Looks To Stop Tax Inversion Deals 8/7/2014
Analysts Believe Vulnerable GlaxoSmithKline (GSK) May Be Pfizer (PFE)'s Plan B 8/6/2014
Sterigenics International, Inc. Completes $826 Million Acquisition Of Nordion Inc. 8/6/2014
Jazz Pharmaceuticals plc (JAZZ) Completes Acquisition Of Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals 8/6/2014
Alvogen Pays $187 Million For Korea's Dream Pharma 8/6/2014
The Cooper Companies, Inc. (COO) Completes Acquisition Of Sauflon Pharmaceuticals Inc. And Announces $700 Million 3-Year Term Loan 8/6/2014
Roche (RHHBY) Bags Santaris Pharma A/S In Deal Worth $450 Million 8/5/2014
CIRCADIAN® Acquires A Controlling Stake In ZircLight Inc. With A Series A Investment Led By Ams AG 8/5/2014
The HallStar Company Expands Organics Portfolio With Florasolvs® Natural Esters Acquisition 8/5/2014
Stem Cell Company ReproCELL (Japan) Acquires 3D Cell Culture Company Reinnervate Limited (UK) And Human Tissue Supplier Bioserve (USA) 8/5/2014
Merck & Co., Inc. (MRK) Completes Tender Offer To Acquire Idenix Pharmaceuticals, Inc. (IDIX) 8/5/2014
Cellular Biomedicine Group (CBMG) Announces Acquisition Of Immune Cell Therapy Technology And U.S. Patent 8/4/2014
ANI Pharmaceuticals, Inc. Acquires Vancocin® Capsules And Additional Vancomycin Assets From Shire 8/4/2014
PCI Announces Completion Of Penn Pharmaceutical Services Purchase 8/4/2014
Institutional Shareholder Services Inc. And Glass Lewis Recommend That Shareholders Of Mallinckrodt And Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Vote FOR Mallinckrodt's Acquisition Of Questcor 8/4/2014
Nordion Receives Investment Canada Act Approval And Announces Expected Closing Date For Acquisition By Sterigenics 8/4/2014
Closing For Pernix Therapeutics, Inc. (PTX) Transaction To Acquire Treximet® Tablets For Migraine From GlaxoSmithKline (GSK) Delayed 8/4/2014
Private Equity Firms Mull $10 Billion Merger Of Older GlaxoSmithKline (GSK), Sanofi (France) (SAN.PA) Brands 8/4/2014
Hedge Funds Bet AstraZeneca PLC (AZN) Will Stay Independent For A Little While Longer 8/4/2014
As The Pursuit For Allergan Inc. (AGN) Continues, Valeant Pharmaceuticals International (VRX) Hunts For More Deals—Including Contact Lenses 8/1/2014
Regeneron Pharmaceuticals, Inc. (REGN), Sanofi (France) (SAN.PA) Bag BioMarin Pharmaceutical Inc. (BMRN)'s Special FDA Priority Review Voucher For $67.5 Million 8/1/2014
Meda AB (MEDA-A.ST) Bags Rottapharm $3.08 Billion To Create A European Pharma Powerhouse 7/31/2014
Cortice Biosciences Announces Acquisition Of Exclusive Rights To A Novel Neurological Disease Therapeutic And Development Platform 7/31/2014
Pfizer Inc. (PFE)’s Stake In Cellectis (ALCLS)’ Capital Is Welcomed By Its Shareholders 7/31/2014
AstraZeneca PLC (AZN) Scoops Up Almirall Lung Drugs For Up To $2.1 Billion 7/30/2014
Pfizer Inc. (PFE) Grabs Baxter International, Inc. (BAX)'s Portfolio Of Marketed Vaccines For $635 Million 7/30/2014
Pfizer Inc. (PFE) CEO Aggressively Seeking Deals, Leaves Investors Guessing On AstraZeneca PLC (AZN) Intentions 7/30/2014
Tigermed And Frontage Laboratories Complete Strategic Investment Agreement 7/30/2014
Cellectis (ALCLS) Sells Its Swedish Unit To Takara Bio For Undisclosed Amount 7/29/2014
Jin-En International Group Holding Co. Acquires Nascent Biotech Inc. And Changes Name To Nascent Biotech Inc. 7/29/2014
Clinuvel Snags A $95 Million Takeover Bid From New York-Based Retrophin, Inc. (RTRX) 7/28/2014
Welichem Biotech Inc. (WBI.V) Ends Effort To Re-Acquire China Rights To Psoriasis Treatment 7/28/2014